112 related articles for article (PubMed ID: 22088976)
1. Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type I diabetic animals.
Moniz T; Amorim MJ; Ferreira R; Nunes A; Silva A; Queirós C; Leite A; Gameiro P; Sarmento B; Remião F; Yoshikawa Y; Sakurai H; Rangel M
J Inorg Biochem; 2011 Dec; 105(12):1675-82. PubMed ID: 22088976
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
5. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
[TBL] [Abstract][Full Text] [Related]
6. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats.
Domingues N; Pelletier J; Ostenson CG; Castro MM
J Inorg Biochem; 2014 Feb; 131():115-22. PubMed ID: 24333827
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
Rangel M; Tamura A; Fukushima C; Sakurai H
J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
[TBL] [Abstract][Full Text] [Related]
9. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
10. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
Passadouro M; Metelo AM; Melão AS; Pedro JR; Faneca H; Carvalho E; Castro MM
J Inorg Biochem; 2010 Sep; 104(9):987-92. PubMed ID: 20627316
[TBL] [Abstract][Full Text] [Related]
11. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
12. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
13. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
14. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
15. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
16. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
17. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
18. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
[TBL] [Abstract][Full Text] [Related]
19. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats.
Briede J; Stivriņa M; Stoldere D; Bisenieks E; Uldriķis J; Poikāns J; Makarova N; Duburs G
Cell Biochem Funct; 2004; 22(4):219-24. PubMed ID: 15248181
[TBL] [Abstract][Full Text] [Related]
20. The plasma glucose lowering action of tetrandrine in streptozotocin-induced diabetic rats.
Chen WC; Hayakawa S; Yamamoto T; Huang LW; Liu IM; Cheng JT
J Pharm Pharmacol; 2004 May; 56(5):643-8. PubMed ID: 15142342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
